PCI Biotech Holding ASA (OSL: PCIB)
Norway
· Delayed Price · Currency is NOK 1.850
+0.050 (2.78%)
Aug 30, 2024, 4:25 PM CET
PCI Biotech Holding ASA Revenue
PCI Biotech Holding ASA had revenue of 1.71M NOK in the quarter ending June 30, 2024, with 825.95% growth. This brings the company's revenue in the last twelve months to 6.00M, up 114.86% year-over-year. In the year 2023, PCI Biotech Holding ASA had annual revenue of 2.99M, down -37.05%.
Revenue (ttm)
6.00M
Revenue Growth
+114.86%
P/S Ratio
n/a
Revenue / Employee
999.83K
Employees
6
Market Cap
69.05M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 2.99M | -1.76M | -37.05% |
| Dec 31, 2022 | 4.75M | -1.52M | -24.28% |
| Dec 31, 2021 | 6.27M | -1.10M | -14.86% |
| Dec 31, 2020 | 7.37M | -2.02M | -21.55% |
| Dec 31, 2019 | 9.39M | -193.00K | -2.01% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medistim ASA | 533.17M |
| Nordhealth AS | 471.77M |
| Nykode Therapeutics AS | 69.44M |
| Photocure ASA | 513.58M |
| Carasent ASA | 254.01M |
| ArcticZymes Technologies ASA | 117.80M |
| Hofseth BioCare ASA | 230.08M |
| Gentian Diagnostics ASA | 151.51M |